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Objectives: Actical® actigraphy is commonly used to monitor athlete sleep. The proprietary 
software, called Actiware®, processes data with three different sleep-wake thresholds (Low, 
Medium or High), but there is no standardisation regarding their use. The purpose of this 
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study was to examine validity and bias of the sleep-wake thresholds for processing Actical® 
sleep data in team sport athletes. 
Design: Validation study comparing actigraph against accepted gold standard 
polysomnography (PSG). 
Methods: Sixty seven nights of sleep were recorded simultaneously with polysomnography 
and Actical® devices. Individual night data was compared across five sleep measures for 
each sleep-wake threshold using Actiware® software. Accuracy of each sleep-wake 
threshold compared with PSG was evaluated from mean bias with 95% confidence limits, 
Pearson moment-product correlation and associated standard error of estimate.  
Results: The Medium threshold generated the smallest mean bias compared with 
polysomnography for total sleep time (8.5 min), sleep efficiency (1.8%) and wake after sleep 
onset (-4.1 min); whereas the Low threshold had the smallest bias (7.5 min) for wake bouts. 
Bias in sleep onset latency was the same across thresholds (-9.5 min). The standard error of 
the estimate was similar across all thresholds; total sleep time ~25 min, sleep efficiency 
~4.5%, wake after sleep onset ~21 min, and wake bouts ~8 counts. 
Conclusions: Sleep parameters measured by the Actical® device are greatly influenced by 
the sleep-wake threshold applied. In the present study the Medium threshold produced the 
smallest bias for most parameters compared with PSG. Given the magnitude of 









Sleep is widely accepted as a critical component of the recovery process for an elite 
athlete.1,2 As such, monitoring an athlete’s sleep has become commonplace as sport 
scientists look for ways to improve sleep, recovery, and optimise performance. Monitoring 
sleep using the accepted gold standard method of polysomnography (PSG) is impractical for 
most athletes since it requires specialist equipment and staff to collect and analyse the data. 
Also, because PSG monitoring often requires the subject to sleep in a laboratory or setting 
outside their home environment, long term monitoring of an individual’s sleep, or monitoring 
multiple athletes simultaneously is problematic. For these reasons, actigraphy has become a 
popular low-cost, non-invasive alternative for collecting sleep data of athletes. Worn on the 
wrist, actigraph monitors contain a multidirectional accelerometer that detects movements 
and employs software algorithms to distinguish sleep from wakefulness based on the level of 
movement.3 These small devices can store several days and nights of data before 
downloading to a computer, allowing users to monitor multiple athletes over consecutive 
nights in any environment; home or away at competition. 
The Actical® (Philips Respironics) is an actigraph commonly employed by sport 
scientists to monitor sleep behaviour in elite athletes.2,4 Data from the Actical® device can be 
converted into a format which allows for processing with the Actiware® analysis software 
(Philips Respironics). This software uses algorithms to process data based on one of three 
Actiware® sleep-wake threshold settings (Low, Medium and High). Although the sleep-wake 
threshold algorithms were originally developed and validated with sleep disordered patients, 
the algorithms and Actical® devices have been validated on a range of populations including 
sleep disordered and healthy adults.5-8 There is however, currently no standardised protocol 
regarding the use of different threshold settings.  
Previous research studies investigating the sleep behaviour of elite athletes have 
used the Medium sleep-wake threshold, based on the work of other industry researchers 
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using this threshold setting.2,4 Recently, researchers compared the validity of wrist 
actigraphy across all three Actiware® threshold settings in elite endurance cyclists.1 Whilst 
good agreement was observed between activity monitors and PSG for each of the three 
sleep-wake thresholds (81-90%), the devices underestimated sleep duration and 
overestimated wake duration depending on which threshold was applied. In contrast to 
studies using the Medium threshold, Sargent et al. (2015) recommended the High sleep-
wake threshold be employed when using Actical® actigraphy with elite cyclists.  
Considering the widespread use of actigraphy with elite athletes, we sought to 
expand to work of Sargent et al. (2015) to include elite team-sport athletes. Due to the lack 
of standardisation of the sleep-wake threshold settings used to analyse Actical® data, the 
aim of this study was to examine the validity and potential bias of the three software 
thresholds compared with polysomnography. Also, given the way the actigraphy and PSG 
data is used in a practical setting, only time matched, overall night data values were used for 
comparison rather than an epoch to epoch analysis which has been used by previous 
researchers.3,7  
Methods 
Participants were 21 male elite team-sport athletes (age: 22.5 ±2.7y) from the 
premier Australian Rules Football League (10) and Australian Rugby League (11). 
Participants completed a Pittsburgh Scale for Evaluation of Sleep Quality questionnaire to 
establish inclusion in the study.9 Exclusion criteria included; shift workers, participants on 
medication which could impact study results, parents with newborns, presence of primary 
sleep disorders, and consumption of more than five caffeine beverages per day. Informed 
consent was obtained from each participant and the study was approved by the Ethics 
Committees of Murdoch University and the Australian Institute of Sport.  
Participants’ sleep was assessed using PSG and concurrent actigraphy on four 
occasions. All athletes were in pre-season training at the time of the study. Data was 
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collected as part of an intervention sleep study which was a randomised, parallel group, 
single blind experimental design comparing neurofeedback to a sham group. Sixty-seven 
successful observations were recorded, after some recordings were excluded due to 
technical issues (n = 16) or participant illness (n = 1). All participants slept in their own 
bedroom within an apartment. Bedtimes and awakening times were ad libitum; however, the 
time when bedroom lights were turned off (bedtime) and on (awakening time) was noted. 
Clocks on the PSG and Actical® devices were synchronised to align the two recording 
devices. For both devices, the following time-matched, summary measures were collected 
and calculated for each night: sleep onset latency (SOL), total sleep time (TST), sleep 
efficiency (SE), wake after sleep onset (WASO) and number of wake bouts. SOL was 
calculated as time from lights out until the onset of sleep. TST calculated as the total 
duration of epochs scored as sleep between lights off and on; SE was defined as the 
percentage of time asleep between lights off and on; WASO was calculated as the number 
of minutes spent awake between sleep onset and final awakening; wake bouts was defined 
as the number of discreet wake periods experienced after sleep onset and before final 
awakening. 
Polysomnography (Compumedics Siesta 802 system; Compumedics, Texas, USA) 
was recorded following the technical specifications of the American Academy of Sleep 
Medicine manual for the scoring of sleep and associated events.10 Polysomnograph 
montage included; four electroencephalogram (EEG) electrodes according to the 
international 10-20 electrode placement system (F4-A1, C4-A1, C3- A2, O2-A1); two 
electrooculogram electrodes (Left and Right eye); chin electromyogram (EMG1, EMG2) 
placed on the mentalis and submentalis; right and left anterior tibialis piezo EMG; thoracic 
and abdominal respiratory bands; pulse oximeter on the index finger of the non-dominant 
hand; oronasal airflow sensor; and a single modified lead 11 placement for 
electrocardiogram (ECG). Signals from each PSG system were stored in a data card within 
the system as well as transmitted to a laptop in an adjacent room where a researcher 
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monitored the signals throughout the night. All data was scored in 30 s epochs according to 
the American Academy of Sleep Medicine scoring criteria by a trained specialist, unaware of 
the participants’ intervention condition.10 The studies were reviewed according to the same 
criteria by a second sleep specialist blinded to the study design. 
Actigraphy data were collected using Actical® Z series activity monitors (Actical® Z 
series part number 198-0200-03; Philips Respironics, Oregon, USA) worn on the non-
dominant wrist. Each activity monitor contains a 3-axis piezoelectric accelerometer sampled 
at 32 Hz, which generates a voltage when it undergoes a change in acceleration. Sensitive 
to movements in the 0.5Hz to 3Hz range, the Actical® device records the mean of activity, or 
movement, sampled each second with the means summed to create activity counts for each 
1 minute epoch. Actiware® 5.61 activity and sleep analysis software (Mini Mitter 
Philips/Respironics, Oregon, USA) was used to set up, download and process the data. An 
activity score was generated for each epoch as a weighted average of the activity count for 
the current epoch and that of the surrounding epochs (±2 min).11 Data from the Actical® was 
assessed as sleep or wake based on whether or not the activity scores exceeded a set wake 
sensitivity threshold. For the purpose of this study, data from the actigraph devices was 
processed for all three wake sensitivity thresholds; Low (> 20 activity counts scored as 
wake), Medium (> 40 activity counts scored as wake), High (> 80 activity counts scored as 
wake). Time in bed was calculated using the ‘lights off’ and ‘lights on’ times recorded on the 
PSG system. SOL was calculated as the time from lights out until sleep onset and as such, 
the results for this sleep parameter do not change across the three sleep-wake thresholds.  
In previous studies, agreement rates of epoch-by-epoch data have been used to 
compare PSG and actigraphy, however this technique is not considered fully appropriate as 
a measure of concordance.3,12 For this reason, and due to the way PSG and actigraphy data 
are reported in a practical setting, time matched overall night data values (TST, SE, SOL, 
WASO and wake bouts) for PSG and Actical® threshold sensitivities (Low, Medium and 
High) were used for comparison.  
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Accuracy of each sleep-wake threshold compared with PSG was evaluated by 
determining mean bias and corresponding ninety-five percent confidence limits (95% CL), as 
well as the Pearson moment-product correlation and associated standard error of estimate 
(SEE). Magnitudes of the Pearson correlations were interpreted using the descriptors of 
Hopkins, low (0.1-0.3), moderate (0.3-0.5), large (0.5-0.7), very large (0.7-0.9).13 Bland-
Altman plots of absolute error in Actical® from the mean of the PSG and Actical® data across 
all sleep parameters were conducted.14 The bias, correlation and Bland-Altman analyses 
were conducted with GraphPad Prism version 6.01 (GraphPad Software, La Jolla California 
USA), with magnitudes from specialised Excel spreadsheets.15  
Results 
Data comparing the three sleep-wake threshold settings on the Actical® devices to PSG are 
presented in Table 1. Bland-Altman plots comparing PSG to Actical® for each sleep-wake 
threshold are depicted in Figure 1. Compared to PSG, the Actical® devices underestimated 
total sleep time and sleep efficiency when the Low threshold was applied, but overestimated 
these measures on the Medium and High thresholds. For total sleep time, the SEE for all 
thresholds were similar and very large positive correlations to PSG were observed (r=0.78 to 
0.85). Similarly, for sleep efficiency measures, the SEE for the three thresholds was almost 
identical, however when using the Low threshold, a low correlation to PSG was observed 
(r=0.27), and a moderate correlation was observed for the Medium and High thresholds 
(r=0.35 and 0.34). 
The average amount of time athletes spent awake after sleep onset was overestimated by 
an average of 15.9 min using the Low threshold. Conversely, the Actical® devices 
underestimated wake time on the Medium and High thresholds by 4.1 and 19.3 min 
respectively. As with sleep efficiency, a low correlation to PSG was observed for the Low 
threshold (r=0.24) and a moderate correlation was observed for the Medium and High 
thresholds (r=0.33 and 0.37) and the SEE was similar across thresholds. Compared to PSG, 
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the Actical® monitor underestimated the number of wake bouts regardless of the sleep-wake 
threshold employed, however these results were not significantly different from that obtained 
from PSG. As with the other sleep parameters, the SEE for all thresholds was practically the 
same, however the Low threshold produced the smallest mean bias. A low correlation with 
PSG was observed with r values of 0.20 for Low, 0.12 for Medium and 0.16 for High 
thresholds. The Actical® devices underestimated sleep latency by an average of 9.5 min with 
a SEE of 15.2 min. The results for this sleep parameter were the same across the three 
thresholds and a low correlation to PSG was observed (r = 0.24). 
Discussion 
In a sport setting, Actical® devices are commonly used to identify athletes requiring 
further education or intervention about their sleep hygiene, and are also used in research 
settings as a measure of sleep quantity and quality.2,4 The results of this study indicate that 
for elite team-sport athletes the interpretation of the Actical® data, and therefore feedback to 
athletes, can vary widely depending on the Actiware® software threshold used to process the 
data. In the present study, the Medium sleep-wake threshold of the Actiware® software 
produced the smallest mean bias compared with PSG for sleep duration, sleep efficiency 
and wake after sleep onset. These findings are in contrast to that of Sargent et al. (2015), 
who reported that the High threshold produced the smallest differences for the same sleep 
parameters compared to the PSG for elite endurance-trained cyclists. Our results are also in 
contrast to other validation studies using the Actical® device with non-athletic populations 
which have recommended using the Low or very low (activity count = 10) thresholds for 
better overall performance compared with PSG.6,7  
The differences between the findings of the present study conducted on elite team-
sport athletes and those of other validation studies noted above may relate to the different 
subject groups and conditions in which studies were conducted. Sargent (2015) used male 
endurance-trained cyclists who were measured during a six-week block of intensified 
9 
 
training. Sargent hypothesised that the heavy training load may have reduced the immobility 
of subjects during sleep, with the possibility that athletes moved more in their sleep due to 
muscle soreness induced by their training. The validation studies conducted by 
Kosmadopoulos and colleagues (2012 & 2014) did not use an elite athlete population, rather 
they used healthy young adults, male and female, sleeping in a laboratory. This setting may 
also influence results as factors such as noise, temperature and light are regulated in a 
sleep laboratory, thereby potentially influencing sleep behaviour.  
Collectively the results of the current and previous validation studies highlight that, 
compared with PSG, actigraphy has limitations when applied to different athletic or non-
athletic populations and should be interpreted with caution. One limitation of the present 
study was that only male athletes were used and as such, similar validation studies should 
be conducted on female athletes. However, given the varying results of the aggregated 
validation studies, the data on women may also be confounded by similar factors such as 
the type of athlete (endurance or team-sport), training phase, and if the data is collected in a 
private residence or a sleep laboratory. 
The present study found that compared to PSG, the athletes’ total sleep time (447 
min) and sleep efficiency were underestimated on the Low threshold (~12 min) and 
overestimated with the Medium (~9 min) and High (~24 min) thresholds. In an applied sense, 
the latter error of about five percent is substantial. The practical relevance of the errors 
compared with PSG are larger for WASO (41 min), which was underestimated when the 
Medium (~37 min) and High (~22 min) thresholds were applied, and overestimated using the 
Low (~31 min) threshold. Indeed the value from the High threshold is approximately half that 
from PSG and would lead to a different interpretation of an athlete’s sleep. Furthermore, 
regardless of the threshold applied, the Actical® devices significantly underestimated sleep 
onset latency by an average of 9.5 mins. Considering a normal sleep latency period is 10-20 
mins, a bias of this magnitude is important when attempting to interpret sleep reports. In 
addition to these observed biases, it is important to note that in the present study the 
10 
 
correlations between the actigraphy and PSG for all sleep parameters, other than total sleep 
time, are only low to moderate. One of the limitations of actigraphy is that it uses movement 
or lack of movement as a surrogate to infer a state of wakefulness or sleep respectively12, 
whereas PSG detects wakefulness and sleep using brain wave activity rather than subject 
mobility.  
As well as investigating the potential systematic bias of each threshold on the 
different sleep parameters, another objective of the study was to understand the uncertainty 
of measures using the Actical® devices. These devices are often used with elite athletes to 
quantify sleep in research studies, and in routine servicing to identify athletes requiring sleep 
hygiene coaching. If the devices are used to longitudinally monitor an athlete’s sleep, care 
must be taken when interpreting any change in measures. The standard error of the 
estimate (SEE) provides users with the typical ‘noise’ or variability of the measure. This 
estimate can be used to interpret changes in sleep reports for athletes. By quantifying the 
random uncertainty of each measure, normally distributed confidence limits (CL) can then be 
employed when interpreting changes in sleep parameters measured with the Actical® 
devices. If one wanted to be conservative, 95% CLs would be employed to help interpret a 
meaningful change in an individual’s sleep measures, where the 95% CL for an individual 
change score is calculated as ± √2 x 1.96 x SEE. A less conservative approach might use a 
52% CL for an individual change score, calculated as ± √2 x 0.71 x SEE. 
This study found the SEE for each sleep parameter was similar regardless of the 
Low, Medium or High software threshold applied. For total sleep duration, the SEE across 
thresholds was approximately 25 min, sleep efficiency 4.5%, WASO 21 min and wake bouts 
approximately 8 counts. The SEE for sleep onset latency was 15.2 min. If one used 95% 
CLs, changes within an individual athlete would have to exceed ± 69 min for sleep duration, 
± 12.5% for sleep efficiency, ± 58 min for WASO, ± 22 counts for Wake Bout, ± 42 min for 
sleep latency. These magnitudes highlight a limitation of using actigraphy on individuals to 
monitor changes longitudinally. Without an understanding of the ‘noise’ of each 
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measurement, changes in sleep measures may be interpreted as genuine, rather than being 
due to the measurement variability of the actigraphy device. In a practical sense, this may 
lead practitioners and researchers to believe a particular sleep intervention has been 
successful when in reality it has not. 
Conclusions 
Results from the present study suggest that whilst the ‘noise’ or imprecision of measures 
from the Actical® devices is similar for the different sleep-wake thresholds, there is less bias 
associated with the Medium threshold for sleep duration, sleep efficiency and WASO. 
Therefore, scientists using Actical® devices to monitor sleep in elite team-sport athletes 
should consider using thresholds that are moderately sensitive to sleep (Medium threshold) 
where activity counts are above 40. Additional validation studies of the Actical® devices with 
elite athlete populations, including female athletes, should be undertaken to understand the 
bias and imprecision of the different sleep-wake threshold settings on data analysis.  
Practical Implications 
 Sleep reports and research using the Actical® devices should indicate which sleep-wake 
threshold was used to process the data.   
 A Medium sleep-wake threshold (activity counts above 40) should be used to process 
sleep data for team sport athletes. 
 The imprecision of actigraphy highlights the importance of utilising confidence limits to 
assess the likelihood of a real change between sleep measures over time. 
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Fig. 1  Bland-Altman plots comparing PSG with the Actical® devices at different sleep-wake 
thresholds (Low, Medium and High) for total sleep time, sleep efficiency, wake after sleep 
onset, wake bouts and sleep onset latency. The solid lines indicate the mean bias from PSG 






Table 1 Comparison of sleep parameters measured by polysomnography (PSG) and 
Actical® activity monitors. Positive values indicate an overestimation by activity monitors 
relative to PSG, and negative values indicate an underestimation by activity monitors relative 
to PSG. 
 
Measure n Mean ± SD Mean bias 
(95% CL) 
SEE r p 
Total Sleep Time (min) 
PSG 
Actical Low (20) 
Actical Medium (40) 
Actical High (80) 
67  
447.1 ± 46.1 
435.2 ± 42.6 
455.6 ± 41.8 
470.8 ± 41.4 
 
 
-11.9 (-19.1 to 4.6) 
8.5 (2.1 to 14.9) 


















Sleep Efficiency (%) 
PSG 
Actical Low (20) 
Actical Medium (40) 
Actical High (80) 
67  
88.7 ± 4.9 
86.3 ± 5.0 
90.5 ± 4.4 
93.5 ± 3.7 
 
 
-2.4 (-3.8 to 0.9) 
1.8 (0.5 to 3.7) 


















Wake After Sleep Onset (min) 
PSG 
Actical Low (20) 
Actical Medium (40) 
Actical High (80) 
67  
41.0 ± 21.6 
56.9 ± 24.0 
36.9 ± 19.9 
21.7 ± 15.6 
 
 
15.9 (9.0 to 22.9) 
-4.1 (-10.0 to 1.8) 















  0.0571  
0.0060* 
0.0024* 
Wake Bouts  
PSG 
Actical Low (20) 
Actical Medium (40) 
Actical High (80) 
67  
31.0 ± 8.4 
23.5 ± 7.0 
18.5 ± 6.1 
13.0 ± 6.1 
 
 
-7.5 (-9.9 to 5.1) 
-12.5 (-15.0 to 10.1) 


















Sleep Onset Latency (min) 
PSG 




16.0 ± 15.5 
6.3 ± 8.3 
 
 










* Significant difference from PSG p <0.05 
 
 
